STJ has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
STJ has been removed from your Stock Email Alerts list.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash to Debt | 0.388 |
STJ's Cash to Debt is ranked lower than
51% of the 366 Companies in the Global Medical Devices industry. ( Industry Median: 1.80 vs. STJ: 0.388 ) |
STJ'
s 10-Year Cash to Debt Range
Min: 0.09 Max: No Debt Current: 0.39 |
| Equity to Asset | 0.442 |
STJ's Equity to Asset is ranked higher than
51% of the 366 Companies in the Global Medical Devices industry. ( Industry Median: 0.60 vs. STJ: 0.442 ) |
STJ'
s 10-Year Equity to Asset Range
Min: 0.44 Max: 0.81 Current: 0.44 |
| Interest Coverage | 16.2 |
STJ's Interest Coverage is ranked higher than
67% of the 366 Companies in the Global Medical Devices industry. ( Industry Median: 9.60 vs. STJ: 16.2 ) |
STJ'
s 10-Year Interest Coverage Range
Min: 8 Max: No Debt Current: 16.2 |
| F-Score: 5 |
|
| Z-Score: 3.13 |
|
| M-Score: -2.79 |
|
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating margin (%) | 20.00 |
STJ's Operating margin (%) is ranked higher than
90% of the 366 Companies in the Global Medical Devices industry. ( Industry Median: 5.40 vs. STJ: 20.00 ) |
STJ'
s 10-Year Operating margin (%) Range
Min: 15 Max: 24.7 Current: 20 |
| Net-margin (%) | 13.7 |
STJ's Net-margin (%) is ranked higher than
88% of the 366 Companies in the Global Medical Devices industry. ( Industry Median: 2.50 vs. STJ: 13.7 ) |
STJ'
s 10-Year Net-margin (%) Range
Min: 2.2 Max: 17.9 Current: 13.7 |
| ROE (%) | 18.4 |
STJ's ROE (%) is ranked higher than
94% of the 366 Companies in the Global Medical Devices industry. ( Industry Median: 3.80 vs. STJ: 18.4 ) |
STJ'
s 10-Year ROE (%) Range
Min: 3 Max: 23.4 Current: 18.4 |
| ROA (%) | 8.1 |
STJ's ROA (%) is ranked higher than
85% of the 366 Companies in the Global Medical Devices industry. ( Industry Median: 2.00 vs. STJ: 8.1 ) |
STJ'
s 10-Year ROA (%) Range
Min: 1.6 Max: 14.2 Current: 8.1 |
| ROC (Joel Greenblatt) (%) | 43.40 |
STJ's ROC (Joel Greenblatt) (%) is ranked higher than
87% of the 366 Companies in the Global Medical Devices industry. ( Industry Median: 9.60 vs. STJ: 43.40 ) |
STJ'
s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 32.4 Max: 59.8 Current: 43.4 |
| Revenue Growth (%) | 6.5 |
STJ's Revenue Growth (%) is ranked higher than
85% of the 366 Companies in the Global Medical Devices industry. ( Industry Median: 0.00 vs. STJ: 6.5 ) |
STJ'
s 10-Year Revenue Growth (%) Range
Min: 6.5 Max: 15.4 Current: 6.5 |
| EBITDA Growth (%) | 3.4 |
STJ's EBITDA Growth (%) is ranked higher than
85% of the 366 Companies in the Global Medical Devices industry. ( Industry Median: 0.00 vs. STJ: 3.4 ) |
STJ'
s 10-Year EBITDA Growth (%) Range
Min: 3.4 Max: 16.6 Current: 3.4 |
| EPS Growth (%) | 1.4 |
STJ's EPS Growth (%) is ranked higher than
86% of the 366 Companies in the Global Medical Devices industry. ( Industry Median: 0.00 vs. STJ: 1.4 ) |
STJ'
s 10-Year EPS Growth (%) Range
Min: 1.4 Max: 79.3 Current: 1.4 |
| David Dreman 446,657 sh (New) Ray Dalio 173,436 sh (+1017.07%) Joel Greenblatt 64,984 sh (+255.55%) John Rogers 1,469,205 sh (+13.4%) Jeremy Grantham 246,281 sh (+5.17%) Bill Frels 1,822,930 sh (+2.88%) Vanguard Health Care Fund 9,110,900 sh (+1.11%) John Hussman 1,251,400 sh (+0.11%) | Andreas Halvorsen Sold Out George Soros Sold Out Mario Gabelli 68,516 sh (-1.87%) James Barrow 362,890 sh (-10.02%) Jim Simons 629,913 sh (-24.42%) Pioneer Investments 930,926 sh (-58.84%) Steven Cohen 3,387 sh (-82.34%) Paul Tudor Jones 14,000 sh (-92.29%) |
| Ken Fisher 34,075 sh (New) Bill Frels 1,875,195 sh (+2.87%) | Vanguard Health Care Fund 9,110,900 sh (unchged) John Hussman 1,251,400 sh (unchged) | Paul Tudor Jones Sold Out Jeremy Grantham 240,900 sh (-2.18%) John Rogers 1,425,780 sh (-2.96%) James Barrow 349,860 sh (-3.59%) Mario Gabelli 62,753 sh (-8.41%) Joel Greenblatt 52,045 sh (-19.91%) David Dreman 317,543 sh (-28.91%) Jim Simons 302,213 sh (-52.02%) Ray Dalio 58,856 sh (-66.06%) Steven Cohen 843 sh (-75.11%) Pioneer Investments 26,000 sh (-97.21%) |
| Sarah Ketterer 562,800 sh (New) Paul Tudor Jones 22,000 sh (New) Ray Dalio 418,456 sh (+610.98%) Ken Fisher 194,705 sh (+471.4%) James Barrow 1,933,300 sh (+452.59%) Steven Cohen 3,994 sh (+373.78%) Joel Greenblatt 73,123 sh (+40.5%) Mario Gabelli 69,673 sh (+11.03%) Vanguard Health Care Fund 10,110,900 sh (+10.98%) Bill Frels 1,886,510 sh (+0.6%) | Jeremy Grantham 235,863 sh (unchged) | Pioneer Investments Sold Out Jim Simons Sold Out John Rogers 1,349,601 sh (-5.34%) John Hussman 1,044,800 sh (-16.51%) David Dreman 144,614 sh (-54.46%) |
| Ken Fisher 308,620 sh (+58.51%) James Barrow 2,735,000 sh (+41.47%) Steven Cohen 5,489 sh (+37.43%) John Rogers 1,675,741 sh (+24.17%) Joel Greenblatt 90,730 sh (+24.08%) Mario Gabelli 81,106 sh (+16.41%) Bill Frels 1,915,010 sh (+1.51%) Jeremy Grantham 236,563 sh (+0.3%) | Paul Tudor Jones Sold Out David Dreman 139,110 sh (-3.81%) Ray Dalio 340,949 sh (-18.52%) Sarah Ketterer 425,000 sh (-24.48%) Vanguard Health Care Fund 7,500,400 sh (-25.82%) John Hussman 4,900 sh (-99.53%) |
| Guru | Date | Trades | Impact to Portfolio | Price Range * (?) | Current Price | Change from Average | Current Shares | |
|---|---|---|---|---|---|---|---|---|
| John Hussman | 2013-03-31 | Reduce -99.53% | 0.99% | $36.14 - $43.12 | $ 45.66 | 12% | 4900 | |
| Vanguard Health Care Fund | 2013-03-31 | Reduce -25.82% | 0.25% | $36.14 - $43.12 | $ 45.66 | 12% | 7500400 | |
| James Barrow | 2013-03-31 | Add 41.47% | 0.06% | $36.14 - $43.12 | $ 45.66 | 12% | 2735000 | |
| Joel Greenblatt | 2013-03-31 | Add 24.08% | 0.04% | $36.14 - $43.12 | $ 45.66 | 12% | 90730 | |
| David Dreman | 2012-12-31 | Reduce -54.46% | 0.18% | $31.37 - $43.69 | $ 45.66 | 22% | 144614 | |
| Ray Dalio | 2012-12-31 | Add 610.98% | 0.13% | $31.37 - $43.69 | $ 45.66 | 22% | 418456 | |
| James Barrow | 2012-12-31 | Add 452.59% | 0.11% | $31.37 - $43.69 | $ 45.66 | 22% | 1933300 | |
| Joel Greenblatt | 2012-12-31 | Add 40.5% | 0.04% | $31.37 - $43.69 | $ 45.66 | 22% | 73123 | |
| Joel Greenblatt | 2012-12-31 | Add 40.5% | 0.04% | $31.37 - $43.69 | $ 45.66 | 22% | 73123 | |
| David Dreman | 2012-09-30 | Reduce -28.91% | 0.12% | $36.32 - $43.04 | $ 45.66 | 17% | 317543 | |
| Ray Dalio | 2012-09-30 | Reduce -66.06% | 0.07% | $36.32 - $43.04 | $ 45.66 | 17% | 58856 | |
| David Dreman | 2012-06-30 | New Buy | 0.42% | $35.19 - $43.75 | $ 45.66 | 18% | 446657 | |
| Joel Greenblatt | 2012-06-30 | Add 255.55% | 0.14% | $35.19 - $43.75 | $ 45.66 | 18% | 64984 | |
| George Soros | 2012-06-30 | Sold Out | 0.1% | $35.19 - $43.75 | $ 45.66 | 18% | 0 | |
| Ray Dalio | 2012-06-30 | Add 1017.07% | 0.09% | $35.19 - $43.75 | $ 45.66 | 18% | 173436 |
More recent guru trades are included for Premium Members only!!
| vs
industry |
vs
history |
||
|---|---|---|---|
| P/E(ttm) | 18.20 |
STJ's P/E(ttm) is ranked higher than
73% of the 217 Companies in the Global Medical Devices industry. ( Industry Median: 22.90 vs. STJ: 18.20 ) |
STJ'
s 10-Year P/E(ttm) Range
Min: 12.71 Max: 78.55 Current: 18.2 |
| P/B | 3.10 |
STJ's P/B is ranked higher than
51% of the 307 Companies in the Global Medical Devices industry. ( Industry Median: 2.30 vs. STJ: 3.10 ) |
STJ'
s 10-Year P/B Range
Min: 2.13 Max: 8.61 Current: 3.1 |
| P/S | 2.60 |
STJ's P/S is ranked higher than
58% of the 333 Companies in the Global Medical Devices industry. ( Industry Median: 2.30 vs. STJ: 2.60 ) |
STJ'
s 10-Year P/S Range
Min: 1.84 Max: 7.3 Current: 2.6 |
| PFCF | 14.00 |
STJ's PFCF is ranked higher than
79% of the 200 Companies in the Global Medical Devices industry. ( Industry Median: 21.03 vs. STJ: 14.00 ) |
STJ'
s 10-Year PFCF Range
Min: 9.89 Max: 60.36 Current: 14 |
| EV-to-EBIT | 13.9 |
STJ's EV-to-EBIT is ranked higher than
78% of the 220 Companies in the Global Medical Devices industry. ( Industry Median: 18.50 vs. STJ: 13.9 ) |
STJ'
s 10-Year EV-to-EBIT Range
Min: 10 Max: 34.3 Current: 13.9 |
| PEG | 1.3 |
STJ's PEG is ranked higher than
81% of the 84 Companies in the Global Medical Devices industry. ( Industry Median: 2.22 vs. STJ: 1.3 ) |
STJ'
s 10-Year PEG Range
Min: 0.72 Max: 3.29 Current: 1.3 |
| Shiller P/E | 20.1 |
STJ's Shiller P/E is ranked lower than
100% of the Companies in the Global Medical Devices industry. ( Industry Median: vs. STJ: 20.1 ) |
STJ'
s 10-Year Shiller P/E Range
Min: 14.36 Max: 71.79 Current: 20.1 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Dividend Yield | 2.10 |
STJ's Dividend Yield is ranked higher than
90% of the 366 Companies in the Global Medical Devices industry. ( Industry Median: 0.00 vs. STJ: 2.10 ) |
STJ'
s 10-Year Dividend Yield Range
Min: 0.39 Max: 2.81 Current: 2.1 |
| Dividend Payout | 0.3785 |
STJ's Dividend Payout is ranked higher than
56% of the 110 Companies in the Global Medical Devices industry. ( Industry Median: 0.30 vs. STJ: 0.3785 ) |
STJ'
s 10-Year Dividend Payout Range
Min: 0.33 Max: 0.39 Current: 0.38 |
| Yield on cost (5-Year) | 2.10 |
STJ's Yield on cost (5-Year) is ranked higher than
89% of the 366 Companies in the Global Medical Devices industry. ( Industry Median: 0.00 vs. STJ: 2.10 ) |
STJ'
s 10-Year Yield on cost (5-Year) Range
Min: 0.39 Max: 2.81 Current: 2.1 |
| Share Buyback Rate | 2.2 |
STJ's Share Buyback Rate is ranked higher than
96% of the 366 Companies in the Global Medical Devices industry. ( Industry Median: 0.00 vs. STJ: 2.2 ) |
STJ'
s 10-Year Share Buyback Rate Range
Min: 2.2 Max: -1.9 Current: 2.2 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Price/Net Current Asset Value | 9.9 |
STJ's Price/Net Current Asset Value is ranked higher than
72% of the 264 Companies in the Global Medical Devices industry. ( Industry Median: 14.30 vs. STJ: 9.9 ) |
STJ'
s 10-Year Price/Net Current Asset Value Range
Min: 8.4 Max: 24.4 Current: 9.9 |
| Price/Tangible Book | 39 |
STJ's Price/Tangible Book is ranked lower than
67% of the 272 Companies in the Global Medical Devices industry. ( Industry Median: 3.90 vs. STJ: 39 ) |
STJ'
s 10-Year Price/Tangible Book Range
Min: 6.3 Max: 34.4 Current: 39 |
| Price/DCF (Projected) | 1.1 | ||
| Price/Median PS Value | 0.6 |
STJ's Price/Median PS Value is ranked higher than
91% of the 284 Companies in the Global Medical Devices industry. ( Industry Median: 0.90 vs. STJ: 0.6 ) |
STJ'
s 10-Year Price/Median PS Value Range
Min: 0.5 Max: 1.7 Current: 0.6 |
| Price/Peter Lynch Fair Value | 1.5 |
STJ's Price/Peter Lynch Fair Value is ranked higher than
81% of the 53 Companies in the Global Medical Devices industry. ( Industry Median: 1.90 vs. STJ: 1.5 ) |
STJ'
s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.9 Max: 2.6 Current: 1.5 |
| Price/Graham Number | 6.1 |
STJ's Price/Graham Number is ranked lower than
63% of the 195 Companies in the Global Medical Devices industry. ( Industry Median: 2.00 vs. STJ: 6.1 ) |
STJ'
s 10-Year Price/Graham Number Range
Min: 2.7 Max: 7.8 Current: 6.1 |
| Earnings Yield (Greenblatt) | 7.20 |
STJ's Earnings Yield (Greenblatt) is ranked higher than
86% of the 366 Companies in the Global Medical Devices industry. ( Industry Median: 2.70 vs. STJ: 7.20 ) |
STJ'
s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.9 Max: 10 Current: 7.2 |
| Forward Rate of Return (Yacktman) | 16.46 |
STJ's Forward Rate of Return (Yacktman) is ranked higher than
96% of the 366 Companies in the Global Medical Devices industry. ( Industry Median: 0.00 vs. STJ: 16.46 ) |
STJ'
s 10-Year Forward Rate of Return (Yacktman) Range
Min: 13 Max: 24.4 Current: 16.46 |
| Industry: | Medical Devices | |
|---|---|---|
| Compare: | MDT, SYK, SMA, ZMH, EW | |
| Traded in other countries: | JUD.Germany |
| comment on STJ Apr 21 2013 |
| Sarah Ketterer Returns 24 Pct in 2012, Her Top Q4 Buys Feb 25 2013 |
| Why Cooperman and Price Are Betting on Boston Scientific’s Turnaround Dec 31 2012 |
| My Best Healthcare Stock Picks For 2013 | Last Year’s Picks Gained 31.55% Dec 04 2012 |
| Weekly CEO Sells Highlight: Entegris, Honeywell International, St Jude Medical and Wesco Internation Nov 05 2012 |
| Six Stocks Will Benefit If Mitt Romeny Wins Oct 08 2012 |
| comment on STJ Oct 07 2012 |
| Medtronic (MDT) Dividend Stock Analysis 2012 Oct 05 2012 |
| -12% in shares Outst Jul 18 2012 |
| Medtronic - A 'Must Own' Stock for 2012 Mar 07 2012 |
| FDA Nod for STJ's Ellipse & Assura - Analyst Blog Jun 13 2013 - ZACKS |